Post-mortem screening reveals rising rate of pregabalin use
In Queensland, forensic services are now routinely testing for the drug
Forensic toxicologists in Queensland are now routinely screening for pregabalin in post-mortems as evidence mounts that patients are misusing the neuropathic pain therapy.
The schedule 4 drug is under increasing scrutiny, including a TGA review, after two Australian studies published last year highlighted rising rates of overdose.
